登录

首页 > 资讯动态

FDA批准Tepezza治疗甲状腺眼病 2020.01.21

FDA approves first treatment for thyroid eye disease FDA批准治疗甲状腺眼病的新疗法 Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where ...